Melanoma
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
Feature
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
From the Journals
New melanoma treatments linked to mortality decline
Melanoma incidence in the U.S. has continued to rise, but BRAF inhibitors and immune checkpoint inhibitors are extending survival, data suggest....
From the Journals
Teledermoscopy using smartphones fails to boost skin cancer detection
From the Journals
Patients accept artificial intelligence in skin cancer screening
Although patient and clinician artificial intelligence tools were acceptable to most patients surveyed, 94% emphasized the importance of a human...
Conference Coverage
Largest meeting on cancer research canceled: AACR